Orforglipron
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 1400
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.